The release of Empaxa | Sana Pharma
The release of Empaxa
Home » SANA Pharma News » The release of Empaxa
Sunday, November 13, 2022

Sana Pharma proudly announces the release of a new medication in the Jordanian market.

Empaxa, Empagliflozin is an oral antidiabetic medication used for the treatment of type 2 diabetes patients. Empaxa has cardio and reno-protective effects, reduces body weight and blood pressure, and is well-tolerated without risk of hypoglycemia.